AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eve Health Ltd

0.019

0.000

Volume:510.12K

Turnover:9.25K

Market Cap:5.41M

PE:-3.06

High:0.019

Open:0.019

Low:0.017

Close:0.019

52wk High:0.040

52wk Low:0.017

Shares:284.88M

Float Shares:135.49M

Volume Ratio:1.03

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.006

EPS(LYR):-0.011

ROE:-77.71%

ROA:-41.55%

PB:1.44

PE(LYR):-1.65

Loading ...

Overview Company News Filings

Eve Health Group Ltd - Cornerstone Investor Commits Additional a$400,000 to Eve Placement

THOMSON REUTERS

BUZZ-Australia's EVE Health slips on discounted placement

Eve Health Group - Seeks Trading Halt for Capital Raising Consideration and Planning

THOMSON REUTERS

Eve Health Group Ltd-Sama Balasubramanian Appointed to Scientific Advisory Board

THOMSON REUTERS

Eve Health Group Ltd-Change of Director's Interest Notice

THOMSON REUTERS

BRIEF-Eve Health Signs Telehealth Services Agreement With Hubmed

Eve Health Group Ltd-Medical Science Liaison Appointed

THOMSON REUTERS

BRIEF-Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share

Eve Health Group - Raises a$1.1M at a$0.030 per Share

THOMSON REUTERS

BRIEF-Eve Health Group Requests Trading Halt For Capital Raising

EVE Health Group Confirms First Australian Prescriptions of Dyspro, Launches Support Platform

Why Investors Can’t Miss Spark Plus Australian Equities Day 2025

EVE Health Group Commences Distribution of Dyspro Gummies to Treat Period Pain

ASX Small-Cap Stocks to Watch

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EVE.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EVE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EVE.AU\",,,,,undefined,":{"symbol":"EVE.AU","market":"AU","secType":"STK","nameCN":"Eve Health Ltd","latestPrice":0.019,"timestamp":1773983520000,"preClose":0.019,"halted":0,"volume":510115,"delay":0,"changeRate":0,"nameEN":"Eve Health Ltd","floatShares":135489321,"shares":284876592,"eps":-0.006208,"marketStatus":"Market Closed","change":0,"latestTime":"03-20 16:12:00 AEDT","open":0.019,"high":0.019,"low":0.017,"amount":9252,"amplitude":0.105263,"askPrice":0.019,"askSize":185231,"bidPrice":0.018,"bidSize":184821,"shortable":3,"etf":0,"ttmEps":-0.006208,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774220400000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.019,"openAndCloseTimeList":[[1773961200000,1773982800000]],"volumeRatio":1.0301753121336825,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EVE.AU","preClose":0.019,"auctionPrice":0.019,"auctionVolume":97500,"auction":3,"marketStatus":"盘后竞价","timestamp":1773982835035}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EVE.AU\",,,,,undefined,":{"symbol":"EVE.AU","floatShares":135489321,"roa":"-41.55%","roe":"-77.71%","lyrEps":-0.011493,"volumeRatio":1.0301753121336825,"shares":284876592,"dividePrice":0,"high":0.019,"amplitude":0.105263,"preClose":0.019,"low":0.017,"week52Low":0.017,"pbRate":"1.44","psRate":"3.98","week52High":0.04,"institutionHeld":0,"latestPrice":0.019,"committee":-0.001108,"eps":-0.006208,"divideRate":0,"volume":510115,"delay":0,"ttmEps":-0.006208,"open":0.019,"prevYearClose":0.021,"prevWeekClose":0.021,"prevMonthClose":0.02,"prevQuarterClose":0.021,"fiveDayClose":0.021,"twentyDayClose":0.02,"sixtyDayClose":0.023,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-02","symbol":"EVE.AU","defaultRemindTime":1748822400000,"type":"split","dateTimestamp":1748786400000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EVE.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620842281","title":"Eve Health Group Ltd - Cornerstone Investor Commits Additional a$400,000 to Eve Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620842281","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620842281?lang=en_us&edition=fundamental","pubTime":"2026-03-18 13:17","pubTimestamp":1773811044,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN4050SW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2619159553","title":"BUZZ-Australia's EVE Health slips on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2619159553","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619159553?lang=en_us&edition=fundamental","pubTime":"2026-03-13 10:47","pubTimestamp":1773370052,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's EVE Health slips on discounted placement** Shares of EVE Health Group EVE.AX fall as much as 9.5% to A$0.019, their largest intraday pct loss since March 6** Health and wellness product maker raises A$904,000  via placement** Placement issue price at A$0.02, a 4.8% discount to stock's last close** Says funds will be used to support the advancement of reformulated pharma programs targeting global markets** More than 269,000 shares traded so far vs 30-day average volume of around 262,000 shares** Stock down 9.5% YTD, including the day's moves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL4N40106U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2618962500","title":"Eve Health Group  - Seeks Trading Halt for Capital Raising Consideration and Planning","url":"https://stock-news.laohu8.com/highlight/detail?id=2618962500","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618962500?lang=en_us&edition=fundamental","pubTime":"2026-03-11 06:16","pubTimestamp":1773180994,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1OI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2616719798","title":"Eve Health Group Ltd-Sama Balasubramanian Appointed to Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2616719798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616719798?lang=en_us&edition=fundamental","pubTime":"2026-03-02 05:17","pubTimestamp":1772399855,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260301:nTUE8LX0QD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2602184183","title":"Eve Health Group Ltd-Change of Director's Interest Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2602184183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602184183?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:19","pubTimestamp":1767907158,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUEBR2ZYK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2584678998","title":"BRIEF-Eve Health Signs Telehealth Services Agreement With Hubmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2584678998","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584678998?lang=en_us&edition=fundamental","pubTime":"2025-11-19 09:16","pubTimestamp":1763514980,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Signs Telehealth Services Agreement With HubmedNov 19 (Reuters) - Eve Health Group Ltd EVE.AX:SIGNS TELEHEALTH SERVICES AGREEMENT WITH HUBMEDFurther company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nFWN3WU18O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2580923930","title":"Eve Health Group Ltd-Medical Science Liaison Appointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2580923930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580923930?lang=en_us&edition=fundamental","pubTime":"2025-11-03 05:19","pubTimestamp":1762118350,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE1RFHGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2574390035","title":"BRIEF-Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2574390035","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574390035?lang=en_us&edition=fundamental","pubTime":"2025-10-09 09:42","pubTimestamp":1759974129,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Group Raises A$1.1 MLN At A$0.030 Per ShareOct 9 (Reuters) - Eve Health Group Ltd EVE.AX:RAISES A$1.1M AT A$0.030 PER SHAREFurther company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VP26Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2574030799","title":"Eve Health Group - Raises a$1.1M at a$0.030 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2574030799","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574030799?lang=en_us&edition=fundamental","pubTime":"2025-10-09 06:25","pubTimestamp":1759962331,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VP26Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVE.AU","BK7141"],"gpt_icon":0},{"id":"2573897249","title":"BRIEF-Eve Health Group Requests Trading Halt For Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2573897249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573897249?lang=en_us&edition=fundamental","pubTime":"2025-10-07 06:20","pubTimestamp":1759789253,"startTime":"0","endTime":"0","summary":"BRIEF-Eve Health Group Requests Trading Halt For Capital RaisingOct 7 (Reuters) - Eve Health Group Ltd EVE.AX:REQUESTS TRADING HALT FOR CAPITAL RAISINGFurther company coverage: EVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nFWN3VN1U4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","EVE.AU"],"gpt_icon":0},{"id":"2572555306","title":"EVE Health Group Confirms First Australian Prescriptions of Dyspro, Launches Support Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2572555306","media":"Small Caps","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572555306?lang=en_us&edition=fundamental","pubTime":"2025-10-01 08:24","pubTimestamp":1759278296,"startTime":"0","endTime":"0","summary":"EVE Health Group has prescribed its Dyspro cannabinoid-based gummy for the treatment of dysmenorrhoea and endometriosis to Australian patients for the first time.EVE issued the drug under the Therapeutic Goods Administration’s Special Access Scheme, marking the company’s transition from production and distribution to real-world patient access.The milestone follows the company’s successful completion of GMP manufacture and distribution, continuing EVE’s commercial rollout.EVE is progressing new partnerships to broaden its prescription and distribution channels, with the aim of scaling patient access and supporting future export opportunities.The company is also developing additional practitioner education initiatives to strengthen awareness and adoption across clinical networks, holding the first in-clinic seminar last week to demonstrate the therapeutic benefits of Dyspro and provide practical prescribing guidance.Prescription of Dyspro comes in parallel with the launch of theReclaim M","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/EVE-Health-ASX-First-Australian-Prescriptions-Dyspro-Launches-Support-Platform.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/EVE-Health-ASX-First-Australian-Prescriptions-Dyspro-Launches-Support-Platform.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/eve-health-group-first-australian-prescriptions-dyspro-launches-support-platform/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/eve-health-group-first-australian-prescriptions-dyspro-launches-support-platform/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["EVE","BK7141","XKO.AU","XJO.AU","EVE.AU","XAO.AU"],"gpt_icon":0},{"id":"2569275577","title":"Why Investors Can’t Miss Spark Plus Australian Equities Day 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2569275577","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569275577?lang=en_us&edition=fundamental","pubTime":"2025-09-24 13:10","pubTimestamp":1758690649,"startTime":"0","endTime":"0","summary":"The Spark Plus Australian Equities Day 2025 is more than just another investor showcase—it’s your gateway to the next generation of ASX growth stories.Across 18 power-packed presentations, this event brings together some of Australia’s most ambitious companies, each sitting at the cutting edge of their sectors and driving innovation that matters.For investors in the region, this is an exclusive opportunity to connect directly with management teams, uncover high-potential opportunities, and gain exposure to the themes shaping global markets.Among the standouts, Harvest Technology  is redefining remote communications with its secure, low-bandwidth streaming technology, and is on track for profitability ahead of schedule.CurveBeam AI  is revolutionising orthopedic diagnostics with its pioneering 3D imaging systems gaining traction in global healthcare markets.Eve Health Group  is a next-generation healthcare provider leveraging telehealth, digital platforms, and patient-centric services t","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/Spark-Plus-Australian-Equities-Day-2025.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/Spark-Plus-Australian-Equities-Day-2025.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/why-investors-cant-miss-spark-plus-australian-equities-day-2025/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/why-investors-cant-miss-spark-plus-australian-equities-day-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK7007","BK7104","BK7016","BK7084","BK4211","XKO.AU","CVB.AU","XJO.AU","HTG.AU","EVE.AU","ISBC","XAO.AU","BK7141","TGM.AU"],"gpt_icon":0},{"id":"2569279076","title":"EVE Health Group Commences Distribution of Dyspro Gummies to Treat Period Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2569279076","media":"Small Caps","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569279076?lang=en_us&edition=fundamental","pubTime":"2025-09-22 09:00","pubTimestamp":1758502812,"startTime":"0","endTime":"0","summary":"EVE Health Group  has commenced dispatching its proprietary women’s health product Dyspro to distribution partners in preparation for an Australian launch.Dyspro is a first-in-class, cannabinoid-based gummy for the symptoms of dysmenorrhoea  and endometriosis, two of the most prevalent and under-addressed conditions in women’s health.Following the completion of commercial-scale production, the product is now available for prescription under established regulatory pathways, with the company expecting first patient access shortly.EVE has established a national prescribing and education partnership with TeleDocs Clinic to provide streamlined access to Dyspro through its telehealth service, supported by a network of more than 3500 Australian pharmacies.EVE is evaluating additional prescription and distribution partnerships to diversify patient access pathways and support future export opportunities.EVE chief scientific officer Dr Stuart Gunzburg said the start of Dyspro sales would be a “m","market":"nz","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-ASX-Distribution-Dyspro-Gummies-Treat-period-pain.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-ASX-Distribution-Dyspro-Gummies-Treat-period-pain.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/eve-health-group-distribution-dyspro-gummies-treat-period-pain/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/eve-health-group-distribution-dyspro-gummies-treat-period-pain/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XAO.AU","EVE.AU","XKO.AU","BK7141","XJO.AU","EVE"],"gpt_icon":0},{"id":"2569275747","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2569275747","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569275747?lang=en_us&edition=fundamental","pubTime":"2025-09-22 07:47","pubTimestamp":1758498431,"startTime":"0","endTime":"0","summary":"Investors are likely to keep their eyes peeled for the following small-cap stocks on the Australian Securities Exchange.EVE Health Group  said that Dyspto, its cannabinoid-based gummy for pain relief for women suffering from dysmenorrhea and endometriosis, can be prescribed via digital consults.Yandal Resources  said reverse circulation drilling at its Ironstone Well-Barwidgee project in Western Australia showed the capacity of the project to host a large-scale mineralized system.Morella  said ground gravity survey at the Mallina Lithium joint venture in Western Australia with Elevra Lithium  identified 12 new high-priority exploration targets with targets up to 100 meters wide and 450 meters long.DY6 Metals  said the soil sampling campaign at its Central Rutile Project in Cameroon has been expanded to include Yaounde West licences and now comprises 1,048 samples, of which 255 samples have been collected.Auric Mining  is set to start its first toll milling campaign at Black Cat Syndica","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","AWJ.AU","BK7104","1MC.AU","XKO.AU","BK7504","XJO.AU","DY6.AU","EVE.AU","BK7141","BK7095","YRL.AU","BC8.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}